News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Asembia 2025 |
Sales Effectiveness|
Latest Executive Roundtables
Advertisement

Pierre Morgon

Advertisement

Articles by Pierre Morgon

line-853396-1416900173890.gif

Medical Affairs: From Info Gatekeeper to Legitimate Value Driver

ByPierre Morgon
September 1st 2014

The role of pharma medical affairs teams is taking on greater importance in the value chain.

Advertisement

Latest Updated Articles

  • line-853396-1416900173890.gif
    Medical Affairs: From Info Gatekeeper to Legitimate Value Driver

    Published: September 1st 2014 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Pfizer’s Proven Playbook: Buy, Partner, Scale, Spin-Off, Optimize

2

Bristol Myers Squibb Expands its Strategic Collaboration with Sarah Cannon Research Institute

3

HHS and FDA Appoint Richard Pazdur as Director of The Center for Drug Evaluation and Research

4

AstraZeneca Stock Becomes UK’s Biggest Stock

5

Pharmaceutical Executive Daily: Wegovy Shows Potential to Treat MASH Patients

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us